Valeo Pharma’s Specialty Products Business Unit is focused on providing Canadian healthcare professionals and patients with innovative hospital specialty products. Redesca, it’s leading specialty product, is a Low Molecular Weight Heparin, an injectable anticoagulant drug used primarily to treat and prevent deep vein thrombosis and pulmonary embolism. Valeo also commercialize additional hospital specialty products.
Only Heparin biosimilar clinically tested, largest global patient exposure, supports affordability (health care).
Ametop Gel 4%
Ametop Gel is indicated for percutaneous local anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation, including intravenous injections of medications.
M-Eslon is a narcotic analgesic distributed by Valeo Pharma in Canada through a license from Ethypharm S.A.